Allergic bronchopulmonary aspergillosis

Revision as of 19:03, 11 June 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Allergic bronchopulmonary aspergillosis

Articles

Most recent articles on Allergic bronchopulmonary aspergillosis

Most cited articles on Allergic bronchopulmonary aspergillosis

Review articles on Allergic bronchopulmonary aspergillosis

Articles on Allergic bronchopulmonary aspergillosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Allergic bronchopulmonary aspergillosis

Images of Allergic bronchopulmonary aspergillosis

Photos of Allergic bronchopulmonary aspergillosis

Podcasts & MP3s on Allergic bronchopulmonary aspergillosis

Videos on Allergic bronchopulmonary aspergillosis

Evidence Based Medicine

Cochrane Collaboration on Allergic bronchopulmonary aspergillosis

Bandolier on Allergic bronchopulmonary aspergillosis

TRIP on Allergic bronchopulmonary aspergillosis

Clinical Trials

Ongoing Trials on Allergic bronchopulmonary aspergillosis at Clinical Trials.gov

Trial results on Allergic bronchopulmonary aspergillosis

Clinical Trials on Allergic bronchopulmonary aspergillosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Allergic bronchopulmonary aspergillosis

NICE Guidance on Allergic bronchopulmonary aspergillosis

NHS PRODIGY Guidance

FDA on Allergic bronchopulmonary aspergillosis

CDC on Allergic bronchopulmonary aspergillosis

Books

Books on Allergic bronchopulmonary aspergillosis

News

Allergic bronchopulmonary aspergillosis in the news

Be alerted to news on Allergic bronchopulmonary aspergillosis

News trends on Allergic bronchopulmonary aspergillosis

Commentary

Blogs on Allergic bronchopulmonary aspergillosis

Definitions

Definitions of Allergic bronchopulmonary aspergillosis

Patient Resources / Community

Patient resources on Allergic bronchopulmonary aspergillosis

Discussion groups on Allergic bronchopulmonary aspergillosis

Patient Handouts on Allergic bronchopulmonary aspergillosis

Directions to Hospitals Treating Allergic bronchopulmonary aspergillosis

Risk calculators and risk factors for Allergic bronchopulmonary aspergillosis

Healthcare Provider Resources

Symptoms of Allergic bronchopulmonary aspergillosis

Causes & Risk Factors for Allergic bronchopulmonary aspergillosis

Diagnostic studies for Allergic bronchopulmonary aspergillosis

Treatment of Allergic bronchopulmonary aspergillosis

Continuing Medical Education (CME)

CME Programs on Allergic bronchopulmonary aspergillosis

International

Allergic bronchopulmonary aspergillosis en Espanol

Allergic bronchopulmonary aspergillosis en Francais

Business

Allergic bronchopulmonary aspergillosis in the Marketplace

Patents on Allergic bronchopulmonary aspergillosis

Experimental / Informatics

List of terms related to Allergic bronchopulmonary aspergillosis

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity response to the fungus Aspergillus fumigatus, the spores of which are ubiquitous in soil and are commonly found in the sputum of healthy individuals. A. fumigatus is responsible for a spectrum of lung diseases commonly grouped under the heading of aspergilloses.

Epidemiology

Estimating the prevalence of ABPA has been made difficult by lack of uniform diagnostic criteria and standardised tests. It usually occurs as a complication of other chronic lung disease, in particular asthma or cystic fibrosis. It is estimated that in the US ABPA may be present in between 0.5 and 2% of all asthma patients.

Immunology and pathophysiology

There is both a type I (atopic) and type III hypersensitivity response. Precipitating antibodies incite a type I acute hypersensitivity reaction with release of immunoglobulin E (IgE) and immunoglobulin G (IgG), resulting in mast cell degranulation with bronchoconstriction and increased capillary permeability. Immune complexes and inflammatory cells are then deposited within the bronchial mucosa leading to tissue necrosis and eosinophilic infiltrate, a type III reaction. The subsequent damage to the bronchial wall causes (proximal) bronchiectasis. Repeated acute episodes left untreated can result in progressive pulmonary fibrosis that is often seen in the upper zones and can give rise to a similar radiological appearance to that produced by tuberculosis.

The main features are therefore:

  • bronchospasm
  • increased mucus production and plugging of distal airways, leading to their collapse
  • bronchiectasis

Clinical picture

Symptoms

Investigations

A full blood count usually reveals eosinophilia more than 10% and there is a raised serum IgE more than 1000ng/ml.

Chest radiography shows various transient abnormalities:

  • consolidation or collapse
  • thickened bronchial wall markings
  • peripheral shadows
  • signs of central bronchiectasis

Aspergillus specific tests:

  • precipitating antibodies to aspergillus species in >90% of cases
  • aspergillus-specific IgE RAST test
  • skin-prick test is almost always positive to Aspergillus fumigatus

Management

The aim of treatment is to suppress the immune reaction to the fungus and to control bronchospasm.

The immune reaction is suppressed using oral corticosteroids:

  • a high dose of prednisolone or prednisone (30 to 45 mg per day) in acute attacks
  • a lower maintenance dose (5-10 mg per day)

Mucus plugs may be removed by bronchoscopic aspiration. It is almost impossible to eradicate the fungus but sometimes itraconazole (an anti-fungal) is used in combination with steroid therapy. Regular monitoring of the condition includes chest x-rays, pulmonary function tests, and serum IgE. The antibody levels usually fall as the disease is controlled, but they may rise again as an early sign of flare-ups.

See also

References

  • Kumar, Parveen (1998). Clinical Medicine. Philadelphia: W.B. Saunders. ISBN 0702020192.
  • Longmore, Murray (2004). Oxford Handbook of Clinical Medicine. Oxford Oxfordshire: Oxford University Press. ISBN 0198525583.
  • Greenberger PA, Patterson R (1988). "Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma". J. Allergy Clin. Immunol. 81 (4): 646–50. PMID 3356845.
  • V.P.Kurup, B.Banerjee, P.A.Greenberger, J.N.Fink. Allergic Bronchopulmonary Aspergillosis: Challenges in Diagnosis. From Medscape General Medicine. full text

External links

Template:SIB

de:Allergische bronchopulmonale Aspergillose

Template:WS